<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04525261</url>
  </required_header>
  <id_info>
    <org_study_id>RPE65-NHS</org_study_id>
    <nct_id>NCT04525261</nct_id>
  </id_info>
  <brief_title>Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene</brief_title>
  <acronym>RPE65-NHS</acronym>
  <official_title>Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Campania &quot;Luigi Vanvitelli&quot;</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Retina Italia Onlus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Campania &quot;Luigi Vanvitelli&quot;</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale:&#xD;
&#xD;
      In preparation for treatment with gene therapy, this study is being conducted in order to&#xD;
      investigate the natural history of Inherited Retinal Dystrophies (IRDs) due to mutations in&#xD;
      RPE65 gene. Such a study will help identify suitable patients for therapeutic intervention.&#xD;
&#xD;
      Methodology:&#xD;
&#xD;
      This is a multicenter retrospective, descriptive chart review study designed to assess&#xD;
      retinal structure and function in subjects with IRDs due to mutation in RPE65 gene by visual&#xD;
      acuity, visual field measurements, Optical Coherence Tomography (OCT), and a number of other&#xD;
      vision-related assessments.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>best correct visual acuity</measure>
    <time_frame>at least one year</time_frame>
    <description>average annual progression rate of best correct visual acuity over the retrospective follow-up period</description>
  </primary_outcome>
  <primary_outcome>
    <measure>visual field</measure>
    <time_frame>at least one year</time_frame>
    <description>average annual progression rate of visual field over the retrospective follow-up period</description>
  </primary_outcome>
  <primary_outcome>
    <measure>optical coherence tomography</measure>
    <time_frame>at least one year</time_frame>
    <description>average annual progression rate of central retinal thickness over the retrospective follow-up period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>microperimetry</measure>
    <time_frame>at least one year</time_frame>
    <description>average annual progression rate of macular sensitivity assessed by microperimetry over the retrospective follow-up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fundus autofluorescence</measure>
    <time_frame>at least one year</time_frame>
    <description>change in fundus autofluorescence over the retrospective follow-up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Full-field Electroretinogram</measure>
    <time_frame>at least one year</time_frame>
    <description>average annual progression rate of full-field electroretinogram responses over the retrospective follow-up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multifocal Electroretinogram</measure>
    <time_frame>at least one year</time_frame>
    <description>average annual progression rate of multifocal electroretinogram responses over the retrospective follow-up period</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Leber Congenital Amaurosis 2</condition>
  <condition>Retinitis Pigmentosa 20</condition>
  <eligibility>
    <study_pop>
      <textblock>
        It is expected that approximately 200 patients may be recruited into the study during the&#xD;
        recruitment period.&#xD;
&#xD;
        Each subject must participate in the informed consent process and provide written informed&#xD;
        consent/assent before any data could be collected.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Must be willing to adhere to protocol as evidenced by written informed consent or&#xD;
             parental permission and subject assent.&#xD;
&#xD;
          -  Subjects diagnosed with Retinitis Pigmentosa or Leber Congenital Amaurosis.&#xD;
&#xD;
          -  Molecular diagnosis showing mutations (homozygotes or compound heterozygotes) in RPE65&#xD;
             gene.&#xD;
&#xD;
          -  Age three years old or older.&#xD;
&#xD;
          -  Minimum of two office / clinic visits encounters with ophthalmic assessment that span&#xD;
             a follow-up period of at least 1 year with the last visit occurring within the last&#xD;
             six months (before signature of informed consent and of study start).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable or unwilling to meet requirements of the study.&#xD;
&#xD;
          -  Participation in a clinical study with an investigational drug during the&#xD;
             retrospective study time period (i.e., from 01/01/1990 to study start date).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Francesca Simonelli, MD</last_name>
    <phone>+390817704501</phone>
    <email>francesca.simonelli@unicampania.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ospedale di Camposampiero, ULSS6 Euganea, Camposampiero</name>
      <address>
        <city>Camposampiero</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marzio Chizzolini, MD</last_name>
      <phone>+39049 9324111</phone>
      <email>marzio.chizzolini@aulss6.veneto.it</email>
    </contact>
    <investigator>
      <last_name>Marzio Chizzolini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesco Parmeggiani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UOC Oculistica - AOU Careggi</name>
      <address>
        <city>Florence</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vittoria Murro, MD</last_name>
      <phone>+39 055 27571</phone>
      <email>vittoria.murro@unifi.it</email>
    </contact>
    <investigator>
      <last_name>Vittoria Murro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Sodi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UOC Oculistica - Ospedale Sacco</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Staurenghi</last_name>
      <phone>+390263631</phone>
      <email>giovanni.staurenghi@unimi.it</email>
    </contact>
    <investigator>
      <last_name>Giovanni Staurenghi</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Paola Salvetti</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UOC Oculistica - Ospedale San Paolo</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luca Rossetti</last_name>
      <phone>+390281843937</phone>
      <email>luca.rossetti@unimi.it</email>
    </contact>
    <investigator>
      <last_name>Luca Rossetti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leonardo Colombo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UOC Oculistica - AOU Università degli Studi della Campania Luigi Vanvitelli</name>
      <address>
        <city>Naples</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesca Simonelli</last_name>
      <phone>+390817704501</phone>
      <email>francesca.simonelli@unicampania.it</email>
    </contact>
    <investigator>
      <last_name>Francesca Simonelli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesco Testa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raffaella Brunetti Pierri, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro di Neuroftalmologia dell'età evolutiva - IRCCS Fondazione Istituto Neurologico Nazionale C. Mondino</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabrina Signorini</last_name>
      <phone>+39 0382 3801</phone>
      <email>sabrina.signorini@mondino.it</email>
    </contact>
    <investigator>
      <last_name>Sabrina Signorini</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giorgia Aprile</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UOC Oculistica - Fondazione IRCCS Policlinico San Matteo</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luciano Quaranta</last_name>
      <phone>+390382526213</phone>
      <email>luciano.quaranta@unipv.it</email>
    </contact>
    <investigator>
      <last_name>Luciano Quaranta</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chiara Bertone</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UOC Oculistica - Ospedale Bambin Gesù di Roma</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luca Buzzonetti</last_name>
      <phone>+39 06 6859 2222</phone>
      <email>luca.buzzonetti@opbg.net</email>
    </contact>
    <investigator>
      <last_name>Luca Buzzonetti</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giancarlo Iarossi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UOC Oculistica - Policlinico Gemelli di Roma</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stanislao Rizzo</last_name>
      <phone>+390630155228</phone>
      <email>stanislao.rizzo@unicatt.it</email>
    </contact>
    <investigator>
      <last_name>Stanislao Rizzo</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benedetto Falsini</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>July 31, 2020</study_first_submitted>
  <study_first_submitted_qc>August 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2020</study_first_posted>
  <last_update_submitted>August 22, 2020</last_update_submitted>
  <last_update_submitted_qc>August 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Campania &quot;Luigi Vanvitelli&quot;</investigator_affiliation>
    <investigator_full_name>Francesca Simonelli</investigator_full_name>
    <investigator_title>Prof</investigator_title>
  </responsible_party>
  <keyword>RPE65-related inherited retinal dystrophies</keyword>
  <keyword>natural history study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blindness</mesh_term>
    <mesh_term>Retinitis</mesh_term>
    <mesh_term>Retinitis Pigmentosa</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Leber Congenital Amaurosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

